Ret Proto-Oncogene antibody
Quick Overview for Ret Proto-Oncogene antibody (ABIN2578853)
Target
See all Ret Proto-Oncogene (RET) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Specificity
- RET
-
Purification
- Affinity purified
-
Immunogen
-
Small Molecule, vitamin A conjugated to OVA.
ImmunogenType: Hapten -
Isotype
- IgG
-
-
-
-
Application Notes
- ELISA (1:100 - 1:200), WB (1:100 - 1:400),
-
Restrictions
- For Research Use only
-
-
-
Concentration
- Lot specific
-
Buffer
- PBS, pH 7.4, 0.02 % sodium azide, 50 % glycerol.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid freeze-thaw cycles.
-
Storage
- 4 °C
-
Storage Comment
- Store at 4°C short term. Aliquot and store at -80°C long term.
-
-
- Ret Proto-Oncogene (RET)
-
Alternative Name
- RET
-
Target Type
- Chemical
-
Background
- Synonyms: RET, Cadherin family member 12, CDHF12, C-ret, Hirschsprung disease 1, HSCR1, Hydroxyaryl-protein kinase, Oncogene ret, Proto-oncogene c-Ret, RET-ELE1, RET51, Ret proto-oncogene, RET transforming sequence, RET43, Men2-ret, MEN2B, MTC1, Receptor tyrosine kinase, CDHR16, MEN2A, PTC, RET9
-
Gene ID
- 5979
-
Pathways
- RTK Signaling, Dopaminergic Neurogenesis, Regulation of Cell Size, Tube Formation
Target
-